Fiche publication
Date publication
mai 2026
Journal
Therapeutic advances in gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Dulai PS, Bamias G, Jairath V, Buisson A, Meyer M, Lindner D, Agboton C, Peyrin-Biroulet L
Lien Pubmed
Résumé
The vedolizumab-specific clinical decision support tool (VDZ-CDST) was developed to predict the probability of a response to vedolizumab treatment in patients with Crohn's disease (CD).
Mots clés
Crohn’s disease, clinical decision support tool, quality of life, symptomatic remission, symptomatic response, vedolizumab
Référence
Ther Adv Gastroenterol. 2026 05 4;19:17562848261436120
